APP and Alzheimer disease: The neuroprotective effects of CARTp on the pathology of AD were studied by Xu et al. They observed Aβ plaque-associated CART immunoreactivity in the hippocampus and cortex of 8-month-old APP/PS1 mice as well as in the cortex of human AD patients [144].